Green tea component, catechin, induces apoptosis of human malignant B cells via production of reactive oxygen species

Clinical Cancer Research

Volumn 11, Issue 16, 2005, Pages 6040-6049

  Nakazato, Tomonori ^a   Ito, Keisuke ^a   Ikeda, Yasuo ^a   Kizaki, Masahiro ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; CATALASE; CYTOCHROME C; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; GLUTATHIONE; GREEN TEA EXTRACT; MANGANESE SUPEROXIDE DISMUTASE; REACTIVE OXYGEN METABOLITE; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; PRIORITY JOURNAL;

APOPTOSIS; ARSENICALS; B-LYMPHOCYTES; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CASPASES; CATECHIN; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; HUMANS; INTRACELLULAR MEMBRANES; MEMBRANE POTENTIALS; MITOCHONDRIA; MULTIPLE MYELOMA; OXIDES; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TEA; TIME FACTORS;

EID: 23844541335     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-2273     Document Type: Article

References (50)

1. Yang CS, Wang ZY. Tea and cancer (review). J Natl Cancer Inst 1993;85:1038-49.
2. Ahmad N, Feyes DK, Nieminen AL, Agarwal R, Mukhtar H. Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst 1997;89:1881-6.
3. 2/M arrest in keratinocytes. Carcinogenesis 1996;17:2367-75.
4. Ahmad N, Cheng P, Mukhtar H. Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate. Biochem Biophys Res Commun 2000;275:328-34.
5. Hampton MB, Fadeel B, Orrenius S. Redox regulation of the caspases during apoptosis. Ann N Y Acad Sci 1998;854:328-35.
6. Troyano A, Fernandez C, Sancho P, de Blas E, Alter P. Effect of glutathione depletion on antitumor drug toxicity (apoptosis and necrosis) in U937 human promyelocytic cells. J Biol Chem 2001;276:47107-15.
7. Sergediene E, Jönsson K, Szymusiak H, Tyrakowska B, Rietjens IMCM, Cenas N. Prooxidant toxicity of polyphenolic antioxidants to HL-60 cells: description of quantitative structure-activity relationship. FEBS Lett 1999;462:392-6.
8. Grad JM, Bahlis NJ, Reis I, Oshiro MM, Dalton WS, Boise LH. Ascorbic acid enhances arsenic trioxide-induced cytotoxicity in multiple myeloma cells. Blood 2001;98:805-13.
9. Miller WH, Jr., Schipper HM, Lee JS, Singer J, Waxman S. Mechanism of action of arsenic trioxide. Cancer Res 2002;62:3893-903.
10. Dai J, Weinberg RS, Waxman S, Jing Y. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Blood 1999;93:268-77.
11. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998;281:1309-12.
12. Kluck R, Bossy-Wetzel E, Green D, Newmeyer D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997;275:1132-6.
13. Yang G, Liao J, Kim K, Yurkow EJ, Yang CS. Inhibition of growth and induction of apoptosis in human cancer cells by tea polyphenols. Carcinogenesis 1998;19:611-6.
14. Nam S, Smith DM, Dou QP. Ester bound-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. J Biol Chem 2001;276:13322-30.
15. Ahmad N, Gupta S, Mukhtar H. Green tea polyphenol epigallocatechin-3- gallate differentially modulates nuclear factor κB in cancer cells versus normal cells. Arch Biochem Biophys 2000;376:338-46.
16. Gupta S, Ahmad N, Nieminen AL, Mulhtar H. Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells. Toxicol Appl Pharmacol 2000;164:82-90.
17. Barthelman M, Bair WB III, Stickland KK, et al. (-)-Epigallocatechin-3- gallate inhibition of ultraviolet B-induced AP-1 activity. Carcinogenesis 1998;19:2201-4.
18. Yang F, Oz HS, Barve S, de Villiers WJ, McClain CJ, Varilek GW. The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-κ B activation by inhibition I κ B kinase activity in the intestinal epithelial cell line IEC-6. Mol Pharmacol 2001;60:528-33.
19. Liberto M, Cobrinik D. Growth factor-dependent induction of p21 (CIP1) by the green tea polyphenol, epigallocatechin gallate. Cancer Lett 2000;154:151-61.
20. Nomura M, Kaji A, He Z, et al. Inhibitory mechanisms of tea polyphenols on the ultraviolet B-activated phosphatidylinositol 3-kinase-dependent pathway. J Biol Chem 2001;276:46624-31.
21. Chen C, Yu R, Owuor ED, Kong AN. Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death. Arch Pharm Res 2000;23:605-12.
22. Mitsiades N, Mitsiades CS, Poulaki V, et al. Biologic sequelae of nuclear factor-κ B blockade in multiple myeloma: therapeutic applications. Blood 2002;99:4079-86.
23. Hideshima T, Chauhan D, Richardson P, et al. NF-κ B as a therapeutic target in multiple myeloma. J Biol Chem 2002;277:16639-47.
24. Mitsiades N, Mitsiades CS, Poulaki V, et al. Apoptotic signaling induced by immunqmodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications. Blood 2002;99:4525-30.
25. Mitsiades CS, Mitsiades NS, McMullan CL, et al. Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications. Proc Natl Acad Sci U S A 2004;101:540-5.
26. Chauhan D, Pandey P, Ogata A, et al. Cytochrome-c dependent and independent induction of apoptosis in multiple myeloma cells. J Biol Chem 1997;272:29995-7.
27. Chauhan D, Hideshima T, Anderson KC. Apoptotic signaling in multiple myeloma: therapeutic implications. Int J Hematol 2002;78:114-20.
28. Putcha GV, Deshmukl M, Johnson EM, Jr. Bax translocation is a critical event in neuronal apoptosis regulation by neuroprotectants Bcl-2 and caspases. J Neurosci 1999;19:7476-85.
29. Tu Y, Renner S, Fleishman A, et al. Bcl-X expression in multiple myeloma: possible indicator of chemoresistance. Cancer Res 1998;58:256-62.
30. Gross A, McDonnel JM, Korsmeyer SJ. Bcl-2 family members and the mitochondria in apoptosis. Genes Dev 1999;13:1899-911.
31. Chauhan D, Hideshima T, Rosen S, Reed JC, Kharbanda S, Anderson KC. Apaf-1/cytochrome c-independent and Smac-dependent induction of apoptosis in multiple myeloma (MM) cells. J Biol Chem 2001;276:24453-6.
32. Simon HU, Haj-Heyia A, Levi-Schaffer F. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 2000;5:415-8.
33. Dvorakova K, Waltmire CN, Payne CM, Tome ME, Briehl MM, Dorr RT. Induction of mitochondrial changes in myeloma cells by imexon. Blood 2001;97:3544-51.
34. Wiseman SA, Balentine DA, Frei B. Antioxidants in tea. Crit Rev Food Sci Nutr 1997;37:705-18.
35. Nakagawa H, Hasumi K, Woo J-T, Nagai K, Wachi M. Generation of hydrogen peroxide primarily contributes to the induction of Fe (II)-dependent apoptosis in Jurkat cells by (-)-epigallocatechin gallate. Carcinogenesis 2004;25:1567-74.
36. Gao N, Rahmani M, Dent P, Grant S. 2-Methoxyestradiol-induced apoptosis in human leukemia cells proceeds through a reactive oxygen species and Akt-dependent process. Oncogene 2005;24:3797-809.
37. Pei X-Y, Dai Y, Grant S. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by proteasome inhibitor Bortezomib and histone deacetylase inhibitors. Clin Cancer Res 2004;10:3839-52.
38. Valcic S, Muders A, Jacobsen NE, Liebler DC, Timmermann BN. Antioxidant chemistry of green tea catechins. Identification of products of the reaction of (-)-epigallocatechin gallate with peroxyl radicals. Chem Res Toxicol 1999;12:382-6.
39. Yang CS, Maliakal P, Meng X. Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol 2002;42:25-54.
40. Hong J, Lu H, Meng X, Ryu JH, Hara Y, Yang CS. Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)-epigallocatechin-3- gallate in HT-29 human colon adenocarcinoma cells. Cancer Res 2002;62:7241-6.
41. Sergediene E, Jönsson K, Szymusiak H, Tyrakowska B, Rietjens IMCM, Cenas N. Prooxidant toxicity of polyphenolic antioxidants to HL-60 cells: description of quantitative structure-activity relationship. FEBS Lett 1999;462:392-6.
42. Sakagami H, Arakawa H, Maeda M, et al. Production of hydrogen peroxide and methionine sulfoxide by epigallocatechin gallate and antioxidants. Anticancer Res 2001;21:2633-41.
43. 2 production in transformed and non-transformed human bronchial cell lines: possible mechanisms of cell growth inhibition and apoptosis induction. Carcinogenesis 2000;21:2035-9.
44. Jing Y, Dai J, Chalmens-Redman RME, Tatton WG, Waxman S. Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway. Blood 1999;94:2102-11.
45. Chen Y-C, Lin-Shiau SY, Lin J-K. Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis. J Cell Physiol 1998;177:324-33.
46. Moridani MY, Scobie H, Salehi P, O'Brien PJ. Catechin metabolism: glutathione conjugate formation catalyzed by tyrosinase, peroxidase, and cytochrome P450. Chem Res Toxicol 2001;14:841-8.
47. Pisters AMW, Newman RA, Coldman B, et al. Phase I trial of oral green tea extract in adult patients with solid tumors. J Clin Oncol 2001;19:1830-8.
48. Jung YD, Ellis LM. Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea. Int J Exp Pathol 2001;82:309-16.
49. Bertolini F, Fusetti L, Cinieri S, Martinelli G, Pruneri G. Inhibition of angiogenesis and induction of endothelial and tumor cell apoptosis by green tea in animal models of human high-grade non-Hodgkin's lymphoma. Leukemia 2000;14:1477-82.
50. Lai HC, Chao WT, Chen YT, Yang VC. Effect of EGCG, a major component of green tea, on the expression of Ets-1, c-Fos, and c-Jun during angiogenesis in vivo. Cancer Lett 2004;213:181-8.